Papillomavirus virus-like particles as anticancer vaccines.

Curr Opin Mol Ther

Cardinal Bemardin Cancer Center & Department of Microbiology & Immunology, Loyola University, Chicago, 2160 S First Avenue, Maywood, IL 60153, USA.

Published: February 1999

Papillomavirus virus-like particles (VLPs) are empty, non-replicative, non-infectious particles that retain conformationally correct epitopes for the generation of antibody responses to the viral capsid proteins. Chimeric human papillomavirus (HPV) virus-like particles incorporating non-structural virus proteins offer an exciting approach for combined prophylactic and therapeutic vaccines against HPV-induced lesions. Both HPV VLPs and chimeric VLPs can induce potent humoral and cellular immune responses when injected into mice, leading to the generation of virus-neutralizing antibodies, priming of CD8+ T-cells and activation of cytotoxic T-cell effector functions. This review summarizes recent advances in the production of chimeric VLPs, the immune response elicited by VLPs and chimeric VLPs, and their ability to generate strong protective and therapeutic antitumor immune responses.

Download full-text PDF

Source

Publication Analysis

Top Keywords

virus-like particles
12
chimeric vlps
12
papillomavirus virus-like
8
vlps chimeric
8
immune responses
8
vlps
6
particles
4
particles anticancer
4
anticancer vaccines
4
vaccines papillomavirus
4

Similar Publications

Background: Hyperphosphorylation and aggregation of neuronal tau protein is a primary pathological hallmark of Alzheimer's disease (AD) and primary tauopathies. The accumulation of aggregated tau as neurofibrillary tangles (NFTs) is closely correlated with neurodegeneration and cognitive decline. Key phosphorylation sites on tau have been established as early biomarkers for disease detection and prediction, with various phosphorylation sites differentially appearing across diseases and disease stages.

View Article and Find Full Text PDF

PEG10 is a retroelement-derived Mart-family gene that is necessary for placentation and has been implicated in neurological disease. PEG10 resembles both retrotransposon and retroviral proteins and forms virus-like particles (VLPs) that can be purified using iodixanol ultracentrifugation. It is hypothesized that formation of VLPs is crucial to the biological roles of PEG10 in reproduction and neurological health.

View Article and Find Full Text PDF

Dissociation of Macromolecules in Laser-Heated Droplets Monitored by CD-MS.

Anal Chem

January 2025

Department of Chemistry, Indiana University, 800 Kirkwood Avenue, Bloomington, Indiana 47401, United States.

Charge detection mass spectrometry (CD-MS) is used to monitor the dissociation of large (300 kDa to 20 MDa) protein complexes in droplets heated with a 10.6 μm CO laser. In this approach, electrospray ionization (ESI) is used to produce charged droplets containing macromolecular complexes.

View Article and Find Full Text PDF

The ongoing global health crisis caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the continuous development of innovative vaccine strategies, especially in light of emerging viral variants that could undermine the effectiveness of existing vaccines. In this study, we developed a recombinant virus-like particle (VLP) vaccine based on the Newcastle Disease Virus (NDV) platform, displaying a stabilized prefusion form of the SARS-CoV-2 spike (S) protein. This engineered S protein includes two proline substitutions (K986P, V987P) and a mutation at the cleavage site (RRAR to QQAQ), aimed at enhancing both its stability and immunogenicity.

View Article and Find Full Text PDF

Development and Application of a Fully Automated Chemiluminescence Enzyme Immunoassay for the Detection of Antibodies Against Porcine Circovirus 3 Cap.

Viruses

December 2024

State Key Laboratory of Swine and Poultry Breeding Industry, National Engineering Center for Swine Breeding Industry, College of Animal Science, South China Agricultural University, Guangzhou 510642, China.

Porcine circovirus 3 (PCV3) is a small non-enveloped circovirus associated with porcine dermatitis and nephropathy syndrome (PDNS). It has occurred worldwide and poses a serious threat to the pig industry. However, there is no commercially available vaccine.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!